Skip to Main Content

Author Details

Michael S Glickman
Memorial Sloan Kettering Cancer Center
1997
101
43
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36610794Mycobacterial helicase Lhr abets resistance to DNA crosslinking agents mitomycin C and cisplatin.Nucleic Acids Res2023
37318217The Rip1 intramembrane protease contributes to iron and zinc homeostasis in <i>Mycobacterium tuberculosis</i>.mSphere2023
37383948WNK1 enforces macrophage lineage fidelity.bioRxiv2023
37141254Roles for mycobacterial DinB2 in frameshift and substitution mutagenesis.Elife2023
36916909The C-Terminal Acid Phosphatase Module of the RNase HI Enzyme RnhC Controls Rifampin Sensitivity and Light-Dependent Colony Pigmentation of Mycobacterium smegmatis.J Bacteriol2023
35149530Single-Cell Transcriptional Profiling Reveals Signatures of Helper, Effector, and Regulatory MAIT Cells during Homeostasis and Activation.J Immunol2022
36040405BCG-Induced Tumor Immunity Requires Tumor-Intrinsic CIITA Independent of MHC-II.Cancer Immunol Res2022
36197089Diisonitrile Lipopeptides Mediate Resistance to Copper Starvation in Pathogenic Mycobacteria.mBio2022
35918328Distinctive roles of translesion polymerases DinB1 and DnaE2 in diversification of the mycobacterial genome through substitution and frameshift mutagenesis.Nat Commun2022
34003742Integrated sensing of host stresses by inhibition of a cytoplasmic two-component system controls <i>M. tuberculosis</i> acute lung infection.Elife2021
33602926Gastrointestinal microbiota composition predicts peripheral inflammatory state during treatment of human tuberculosis.Nat Commun2021
33785614The DnaK Chaperone System Buffers the Fitness Cost of Antibiotic Resistance Mutations in Mycobacteria.mBio2021
34183838Inherited PD-1 deficiency underlies tuberculosis and autoimmunity in a child.Nat Med2021
34038719Structural basis for aggregate dissolution and refolding by the Mycobacterium tuberculosis ClpB-DnaK bi-chaperone system.Cell Rep2021
32511541Determinants of Severity in Cancer Patients with COVID-19 Illness.medRxiv2020
33077620Efficient 5-OP-RU-Induced Enrichment of Mucosa-Associated Invariant T Cells in the Murine Lung Does Not Enhance Control of Aerosol Mycobacterium tuberculosis Infection.Infect Immun2020
32680964Bacterial immunotherapy for cancer induces CD4-dependent tumor-specific immunity through tumor-intrinsic interferon-γ signaling.Proc Natl Acad Sci U S A2020
32727901A multilayered repair system protects the mycobacterial chromosome from endogenous and antibiotic-induced oxidative damage.Proc Natl Acad Sci U S A2020
30767816Viral oncolytic immunotherapy in the war on cancer: Infection control considerations.Infect Control Hosp Epidemiol2019
31471114Editorial overview: Attrition warfare: host cell weapons against intracellular pathogens, and how the pathogens fight back.Curr Opin Immunol2019
31239378Two Accessory Proteins Govern MmpL3 Mycolic Acid Transport in Mycobacteria.mBio2019
31207604TOX is a critical regulator of tumour-specific T cell differentiation.Nature2019
29401462Synthesis, stabilization, and characterization of the MR1 ligand precursor 5-amino-6-D-ribitylaminouracil (5-A-RU).PLoS One2018
29991407Blood transcriptomic markers of Mycobacterium tuberculosis load in sputum.Int J Tuberc Lung Dis2018
30124972Challenges for the MD Physician-Scientist Upon Entering the Lab: From the Grand to the Practical.J Infect Dis2018
30228238The Microbiome and Tuberculosis: Early Evidence for Cross Talk.mBio2018
30174294Mycobacterial Mutagenesis and Drug Resistance Are Controlled by Phosphorylation- and Cardiolipin-Mediated Inhibition of the RecA Coprotease.Mol Cell2018
29871936The Canonical Wnt Pathway Drives Macropinocytosis in Cancer.Cancer Res2018
30297823Rifamycin congeners kanglemycins are active against rifampicin-resistant bacteria via a distinct mechanism.Nat Commun2018
30282828Mucosal-associated invariant and γδ T cell subsets respond to initial Mycobacterium tuberculosis infection.JCI Insight2018
28067618Structure and function of the mycobacterial transcription initiation complex with the essential regulator RbpA.Elife2017
29308399Nontuberculous Mycobacterial Infections After Silicone Breast Implant Reconstruction Emphasize a Diversity of Infecting Mycobacteria.Open Forum Infect Dis2017
29052269Control of biotin biosynthesis in mycobacteria by a pyruvate carboxylase dependent metabolic signal.Mol Microbiol2017
28883399Antibiotic treatment for Tuberculosis induces a profound dysbiosis of the microbiome that persists long after therapy is completed.Sci Rep2017
28683818Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy.Microbiome2017
28057704<i>Mycobacterium tuberculosis</i> protease MarP activates a peptidoglycan hydrolase during acid stress.EMBO J2017
27899634Homologous recombination mediated by the mycobacterial AdnAB helicase without end resection by the AdnAB nucleases.Nucleic Acids Res2017
27899559Division of labor among Mycobacterium smegmatis RNase H enzymes: RNase H1 activity of RnhA or RnhC is essential for growth whereas RnhB and RnhA guard against killing by hydrogen peroxide in stationary phase.Nucleic Acids Res2017
27078065Adding Insult to Injury: Exacerbating TB Risk with Smoking.Cell Host Microbe2016
27872278Reconstitution of a Mycobacterium tuberculosis proteostasis network highlights essential cofactor interactions with chaperone DnaK.Proc Natl Acad Sci U S A2016
26901151Control of T cell antigen reactivity via programmed TCR downregulation.Nat Immunol2016
26195593RecF and RecR Play Critical Roles in the Homologous Recombination and Single-Strand Annealing Pathways of Mycobacteria.J Bacteriol2015
26515268Clinical and radiographic differentiation of lung nodules caused by mycobacteria and lung cancer: a case-control study.BMC Infect Dis2015
24492433The mechanism of action of BCG therapy for bladder cancer--a current perspective.Nat Rev Urol2014
26104351Double-Strand DNA Break Repair in Mycobacteria.Microbiol Spectr2014
25222597Novel imidazoline antimicrobial scaffold that inhibits DNA replication with activity against mycobacteria and drug resistant Gram-positive cocci.ACS Chem Biol2014
25058675An essential nonredundant role for mycobacterial DnaK in native protein folding.PLoS Genet2014
25089258Genome-Wide Mapping of the Distribution of CarD, RNAP Ͽ<sup>A</sup>, and RNAP β on the <i>Mycobacterium smegmatis</i> Chromosome using Chromatin Immunoprecipitation Sequencing.Genom Data2014
25170075RecO protein initiates DNA recombination and strand annealing through two alternative DNA binding mechanisms.J Biol Chem2014
24816608The Rip1 protease of Mycobacterium tuberculosis controls the SigD regulon.J Bacteriol2014
  • 1 - 50 of 101

Recommended Authors

Jennifer M Hayashi
Gladstone Institutes
Career Start Year 2012
Number of shared co-authors 1
Bryan D Bryson
Massachusetts Institute of Technology, USA The Ragon Institute of MGH
Career Start Year 2012
Number of shared co-authors 2
Connie Chen
University of California davis
Career Start Year 2009
Number of shared co-authors 0
Rebekah M Dedrick
University of Pittsburgh
Career Start Year 2009
Number of shared co-authors 1
Samantha L Bell
College of Medicine, Rutgers New Jersey Medical School
Career Start Year 2009
Number of shared co-authors 3
Seemay Chou
University of California - San Francisco
Career Start Year 2007
Number of shared co-authors 2
Richard Copin
Regeneron Pharmaceuticals
Career Start Year 2007
Number of shared co-authors 0
Bree B Aldridge
Tufts University School of Engineering
Career Start Year 2006
Number of shared co-authors 2
Andrew J Olive
College of Osteopathic Medicine, Michigan State University
Career Start Year 2006
Number of shared co-authors 4
Kristine M Guinn
Harvard T. H. Chan School of Public Health
Career Start Year 2003
Number of shared co-authors 0
Robert O Watson
Texas A&M University School of Medicine
Career Start Year 2001
Number of shared co-authors 2
Sarah A Stanley
University of California berkeley
Career Start Year 2001
Number of shared co-authors 3
Kristin L Patrick
Texas A&M University School of Medicine
Career Start Year 2001
Number of shared co-authors 2
Antje Blumenthal
Frazer Institute, The University of Queensland
Career Start Year 2001
Number of shared co-authors 0
Reto Guler
International Centre for Genetic Engineering and Biotechnology
Career Start Year 1999
Number of shared co-authors 0
Shamira J Shallom
Clinical Center
Career Start Year 1998
Number of shared co-authors 0
Zhonghe Sun
Jiangsu University
Career Start Year 1997
Number of shared co-authors 1
Arnab Pain
King Abdullah University of Science and Technology
Career Start Year 1997
Number of shared co-authors 0
Paul de Figueiredo
Texas A&M University, College Station
Career Start Year 1995
Number of shared co-authors 2
Rodrigo Andres Floto
University of Cambridge
Career Start Year 1995
Number of shared co-authors 1
Marianna Orlova
The Research Institute of the McGill University Health Centre
Career Start Year 1994
Number of shared co-authors 4
James R Brown
GlaxoSmithKline Pharma R&D, 1250 S. Collegeville Rd, Collegeville
Career Start Year 1994
Number of shared co-authors 0
Istv??n Nagy
Institute of Biochemistry, HUN-REN Biological Research Centre
Career Start Year 1991
Number of shared co-authors 0
Michele S Swanson
University Of Michigan ann arbor
Career Start Year 1990
Number of shared co-authors 1
David R Sherman
University of Washington
Career Start Year 1987
Number of shared co-authors 1
Joel D Ernst
University of California san francisco
Career Start Year 1986
Number of shared co-authors 1
Larry S Schlesinger
Texas Biomedical Research Institute
Career Start Year 1984
Number of shared co-authors 1
Graham F Hatfull
University of Pittsburgh
Career Start Year 1980
Number of shared co-authors 1
Maria Laura Gennaro
Public Health Research Institute, Rutgers New Jersey Medical School
Career Start Year 1980
Number of shared co-authors 0
Raphael H Valdivia
Duke University
Career Start Year 1978
Number of shared co-authors 4

Collaborators

Allison Fay
Memorial Sloan Kettering Cancer Center
Co-authored papers 10
Richa Gupta
Sloan Kettering Institute
Co-authored papers 9
Matthew F Wipperman
Regeneron Pharmaceuticals, Inc.
Co-authored papers 6
Krishna M Sinha
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
John A Buglino
Sloan Kettering Institute
Co-authored papers 4
Seth A Darst
The Rockefeller University
Co-authored papers 4
Oyindamola Adefisayo
Sloan Kettering Institute
Co-authored papers 3
Brook E Heaton
Duke University School of Medicine
Co-authored papers 2
Nicholas D Socci
Co-authored papers 2
Ronald C Hendrickson
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Robert Landick
University of Wisconsin-Madison
Co-authored papers 2
Jeffrey R Johnson
Gladstone Institutes
Co-authored papers 2
Henry Evans
Columbia University Vagelos College of Physicians and Surgeons
Co-authored papers 2
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers 2
Andrea Schietinger
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Hannah Y Wen
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
David Langlais
McGill University
Co-authored papers 1
Wuxing Yuan
Center for Cancer Research, National Cancer Institute
Co-authored papers 1
Li Kai Wang
Sloan-Kettering Institute
Co-authored papers 1
Rajesh K Soni
Herbert Irving Comprehensive Cancer Center, Columbia University
Co-authored papers 1
Nadine Czudnochowski
University of California san francisco
Co-authored papers 1
Sílvia Vilarinho
Co-authored papers 1
Thomas R Ioerger
Co-authored papers 1
Jeremy M Rock
The Rockefeller University
Co-authored papers 1
Paul Zumbo
Co-authored papers 1
Christina S Leslie
Co-authored papers 1
John G Doench
Co-authored papers 1
Oren S Rosenberg
University of California san francisco
Co-authored papers 1
Astha Nautiyal
Sloan Kettering Institute
Co-authored papers 1
Richard P Lifton
The Rockefeller University
Co-authored papers 1
Release 1.2